Immunity to influenza in the elderly

Vaccine

Volumn 18, Issue 16, 2000, Pages 1686-1689

  Webster, Robert G ^a  

^a St Jude Children's Research Institute   (United States)

Author keywords

Elderly; Humans; Influenza

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 2;

AGED; AGING; CALORIC RESTRICTION; CELLULAR IMMUNITY; CYTOKINE RELEASE; HUMAN; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; VIRUS IMMUNITY;

EID: 0033954496     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00507-1     Document Type: Article

References (39)

1. Murphy B.R., Webster R.G. Orthomyxoviruses. Fields B.N., et al. Fields Virology. 1998;1397-1447 Raven Press, New York.
2. Stevens D.J., Douglas A.R., Skehel J.J., Wiley D.C. Antigenic and amino acid sequence analysis of the variants of H1N1 influenza virus in 1986. Bull. World Health Organ. 65:1987;177-180.
3. Air G.M., Gibbs A.J., Laver W.G., Webster R.G. Evolutionary changes in influenza B are not primarily governed by antibody selection. Proc. Natl. Acad. Sci. USA. 87:1990;3884-3888.
4. Taubenberger J.K., Reid A.H., Kraft A.E., Bijwaard K.E., Fanning T.G. Initial genetic characterization of the 1918 'Spanish' influenza virus. Science. 275:1997;1793-1796.
5. Reid A.H., Fanning T.G., Hultin J.V., Taubenberger J.K. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. USA. 96:1999;1651-1656.
6. Couch R.B., Kasel J.A., Glezen W.P., et al. Influenza: its control in persons and populations. J. Infect. Dis. 153:1986;432-440.
7. Wijma G., Ligthart G.J. Influenza vaccination for all elderly. Gerontology. 42:1996;270-273.
8. Barker W.H., Mullooly J.P. Impact of epidemic type A influenza in a defined adult population. Am. J. Epid. 112:1980;798-813.
9. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331:1994;778-784.
10. Govaert T.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 272:1994;1661-1665.
11. Ahmed A.H., Nicholson K.G., Nguyen van Tam J.S. Reduction in mortality associated with influenza vaccine during 1989-1990 epidemic. Lancet. 346:1995;591-595.
12. Glezen W.P. Emerging infections: pandemic influenza. Epid. Rev. 18:1996;64-76.
13. Falsey A.R., Cunningham C.K., Barker W.H., et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis. 172:1995;389-394.
14. Glezen W.P., Decker M., Joseph S.W., Mercready R.G. Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J. Infect. Dis. 155:1987;1119-1126.
15. Hayflick L. The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp. Cell. Res. 23:1961;14-20.
16. Effros R.B., Boucher N., Porter V., et al. Decline in CD28+ cells in centenarians and in long-term T-cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29:1994;601-609.
17. Effros R.B., Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today. 18:1997;450-454.
18. Effros R.B., Walford R.L. The immune response of aged mice to influenza: diminished T-cell proliferation, IL-2 production and cytotoxicity. Cell Immunol. 81:1983;298-305.
19. Bender B.S., Johnson M.P., Small P.A. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. J. Immunol. 72:1991;514-519.
20. Mbawuike I.N., Lange A.R., Couch R.B. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Vir. Immunol. 6:(1):1993;55-64.
21. Thoman M.L., Weigle W.O. The cellular and subcellular basis of immunoescence. Adv. Immunol. 46:1989;221-226.
22. Powers D.C. Immunity to influenza in the elderly. Powers D.C., Morley J.E., Coe R.M. Aging, Immunity, and Infection. 1994;41-55 Springer, New York.
23. McElhaney J.E., Gravenstein S., Upshaw C.M., Hooton J.W., Krause P., Drinka P. Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets. Vaccine. 16:(4):1998;403-409.
24. Miller R.A. Aging and the immune response. Schneider E., Rowe J. Handbook of the biology of aging. 1996;355-392 Academic Press, San Diego.
25. Vaziri H., Schachter F., Uchida I., et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:1993;661-667.
26. Effros R.B., Boucher N., Portner V., et al. Decline in CD28+ T cells in centenarians and in long-term T-cell cultures a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29:1994;601-609.
27. D'Alessio D.J., Cox P.M. Jr, Dick E.C. Failure of activated influenza vaccine to protect an aged population. J. Am. Med. Assoc. 210:1969;485-489.
28. Ferry B.J., Evered M.G., Morrison E.I. Difference protection rates in various groups of volunteers given subunit influenza vaccine in 1976. J. Infect. Dis. 39:1979;237-241.
29. Hobson D.D., Curry R.L., Beare S., Gardner A. The role of serum hemagglutination-inhibiting antibody in protection against challenger infection with influenza A2 and B virus. J. Hyg. 70:1972;767-777.
30. Govaert T.M.E., Sprenger M.J.W., Dinant G.J., Aretz K., Masurel N., Knottnerus J.A. Immune responses to influenza vaccination in elderly people - a randomized double placebo-controlled trial. Vaccine. 12:1994;1185-1189.
31. Gross P.A., Quinnan G.V., Weksler M.E., Gaerlan P.F., Denning C.R. Immunization of elderly people with high doses of influenza vaccine. J. Am. Geriatr. Soc. 36:1988;209-212.
32. Ershler W.B. Influenza vaccination in the elderly: can efficacy be enhanced? Geriatrics. 43:1988;79-83.
33. Gravenstein S., Duthie E.H., Miller B.A., et al. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study. J. Am. Geriatr. Soc. 37:1989;1-8.
34. Brown C.S., Pietrobon P.J., Farr B., Schleupner M., Gravenstein S. Results from a multicenter study to determine the protective efficacy of investigational conjugate influenza vaccine in elderly nursing home population. FASEB J. 3:1989;A1136.
35. Effros R.B., Cassillas A., Walford R.L. The effect of thymosin-〈, of immunity to influenza in aged mice. Aging. 1:1988;31-40.
36. Mier J.W., Vachino G., Van der Meer J.W.M., et al. Induction of circulating tumor necrosis factor (TNF 〈) as the mechanism for the febrile response to interleukin-2 (IL2) in cancer patients. J. Clin. Pharmacol. 8:1988;426-436.
37. Weindruch R., Walford R.L. The retardation of aging and disease by dietary restriction. 1988;Thomas, Springfield, IL.
38. Effros R.B., Walford R.L., Weindruch R., Mitcheltree C. Influences of dietary restriction on immunity to influenza in aged mice. J. Gerontol. Biol. Sci. 46B:1991;142-147.
39. Spaulding C.C., Walford R.L., Effros R.B. The accumulation of non-replicative non-functional, senescent T cells with age is avoided in calorically restricted mice by an enhancement of T-cell apoptosis. Mech. Age. Dev. 93:1997;25-33.